NLS Pharmaceutics : UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS - Form 6-K -December 06, 2023 at 04:49 pm EST
UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS Page ...
Source: marketscreener.com
📰 Chad Hellmann News
Chad Hellmann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chad Hellmann. Real-time updates on events, politics, business and more.
NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer
ZÜRICH, SWITZERLAND / ACCESSWIRE / May 8, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and
Alex Zwyer Keith Harrison Dewedoff Marianne Lambertson Kaizen Bioscience Kellogg College Pharmaceutics Ltd
Source: finanznachrichten.de
Investegate |NLS Pharmaceutics AG Announcements | NLS Pharmaceutics AG: NLS Pharmaceutics Issues Letter to Shareholders
Investegate announcements from NLS Pharmaceutics AG, NLS Pharmaceutics Issues Letter to Shareholders
Source: investegate.co.uk
NLS Pharmaceutics AG: NLS Pharmaceutics CEO Issues Letter to Shareholders
ZURICH, SWITZERELAND / ACCESSWIRE / December 22, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery
Source: finanznachrichten.de